Measles: Epidemiological Characteristics and Associated Factors of Patients Admitted to the Infectious Diseases Unit at the Brazzaville University Hospital

Ossibi Ibara BR^{1, 2,} , Attinsounon CA³, Atipo-Tsiba PW^{1, 4}, Adoua Doukaga T^{1, 2}, Ollondzobo L.C^{1, 5}, Amona M.⁶, Angonga Pabota E.², Ekat M.², EKOUYA BOWASSA G.^{1, 5}, Okoko AR^{1, 5}, Mabiala-Babela JR^{1, 5} and MBIKA Cardorelle^{1, 5}

¹Faculty of Health Sciences, Marien-Ngouabi University, Brazzaville-Congo

²Department of Infectious Diseases, CHU-Brazzaville, CONGO

³Department of Medicine, University of Parakou, Benin

⁴Ophthalmology Department, Brazzaville-Congo University Hospital

⁵Pediatric Department, CHU Brazzaville-Congo

⁶Department of Infectious Diseases, MOBENGO Military Hospital, Brazzaville-CONGO

Cite this paper:
Ossibi Ibara BR, Attinsounon CA, Atipo-Tsiba PW, Adoua Doukaga T, Ollondzobo L.C, Amona M., Angonga Pabota E., Ekat M., EKOUYA BOWASSA G., Okoko AR, Mabiala-Babela JR and MBIKA Cardorelle. Measles: Epidemiological Characteristics and Associated Factors of Patients Admitted to the Infectious Diseases Unit at the Brazzaville University Hospital. American Journal of Infectious Diseases and Microbiology. 2019; 7(1):13-17. doi: 10.12691/ajidm-7-1-3

Abstract

Objectives. To describe the epidemiological aspects of measles cases admitted to the Infectious Diseases Unit and to identify associated factors. Methodology. This is a prospective study based on a descriptive and an analytical study of measles cases admitted to the Infectious Diseases Unit between December 15, 2017 and March 15, 2018. Results. Thirty-eight patients were admitted (3.6% of admissions), predominantly male (n = 24, 63.2%), mean age 2.5 ± 2.6, Brazzaville resident (n = 34; 5%) with no vaccination status (n = 32, 84.2%). The fathers’ average age was 34.74 years (23-52 years) with a primary education level in 44.7% of cases (n = 17). The mothers’ average was 29.39 years (18-40 years) and 45% of them had a primary level of education. The patients had an average of 6.16 ± 2 days for fever (n = 38, 100%); skin rash (n = 37, 97.4%), convulsions (n = 7, 18.4%) and rhinorrhea (n = 18, 47.4%). The average weight was 11.16 kilos (8-16 kg). 11 patients showed cases of malnutrition (28.9%). Retroviral serology and thick blood were positive in 6 patients (15.8%) respectively. The mean duration of hospitalization was 6.84 ± 1 days. The evolution was positive for 34 patients (89.5%). Four patients (10.5%) died. Seizures (P = 0.000), undernutrition (p = 0.013) and anemia (p = 0.000) had a statistically significant influence on the occurrence of death in patients. Conclusion. Measles remains a public health problem in Congo, especially among children who have not been or have been inadequately vaccinated. The dreadful complications justify the emergency of the prevention which passes by the systematic vaccination of the target population in order to stop the chain of transmission.

Keywords:
measles associated factors CHU-Brazzaville

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Organisation Mondiale de la Santé (OMS). Flambées de rougeole et progrès accomplis en vue d’atteindre les objectifs de pré élimination de rougeole : Région africaine de l’OMS, 2009-2010. Wkly Epide Record 2011 ; 86 : 129-40.
[2]	Sahuguede P., Roisin A., Sanou I., Nacro B., Tall F. Epidémie de rougeole au Burkina Faso: 714 cas hospitalisés à l’hôpital de Bobo-Dioulasso. Etude des facteurs de risque. Ann Pédiat. (Paris), 1989 ; 4 :244-51.
[3]	Caseris M, Burdet C, Lepeule R, et al. Actualité de la rougeole. Rev Med Intern. 2015 ; 36 :339-45.
[4]	Flored D. Rougeole : quelles leçons tirer de l’épidemie ? Journal des Anti-infectieux. 2014; 16: 131-6.
[5]	Zachariah P, Stockwell MS. Measles vaccine: past, present and future. J Clin Pharmacol. 2016 ; 56 :133-40
[6]	Anonyme. Définition de la rougeole. Document WHO/EPI/GEN 1993 ; 21 :14.
[7]	E. D’Ortenzio, D. Sissoko, D. Landreau, T.benoit-Cattin, P. Renault V. Pierre. Epidémie de rougeole à Mayotte, océan Indien, 2005-2006. Médecine et maladies infectieuses. 2008 ; 38 : 601-607.
[8]	Organisation Mondiale de la santé(OMS). Vaccins contre la rougeole. Wkly Epide record 2009 ; 84 :349-60.
[9]	Camara B, Diouf S, Diagne I, et al. Complications de la rougeole et facteurs de risque de décès. Méd Afr Noire 2000 ; 47 :8-9.
[10]	C. Biron, O. Beaudoux, A. Ponge, V. Briend-Godet, F. Corne, D. Tripodi, I et al. Rougeole au CHU de Nantes au cours de l’épidémie 2008-2009. Médecine et maladies infectieuses 2011 ; 41 : 415-423.
[11]	Boushab B.M, Savadogo M, Sow M.S, Dao S. Aspects épidémiologiques, cliniques et pronostiques de la rougeole au Centre hospitalier régional d’Aïoun, Mauritanie. Médecine et Santé Tropicales 2015 ; 25 :180-183.
[12]	Simen-Kapeu A, Djerea K, tiemfre I. La rougeole en milieu peri-urbain en Cote d’Ivoire. Evaluation de la gravité et étude des facteurs de complications. Med Afr Noire 2009 ; 56 :8-9.
[13]	F. Simon, M.I. Dordain-Bigot. Manifestations cutanées et muqueuses au cours de la rougeole en Afrique noire. Méd Mal Infcet 1999 ; 29 :551-61.
[14]	C. Speziani, D. laine, C. Servet-Delprat, H. Valentin, C. rabourdin-Combe. Virus de la rougeole et immunodépression. Médecine et maladies infectieuses 2004 ; 34 : S2-S6.
[15]	Embree JE, Datta P, Stackiw W, Sekta L, Braddick M, Kreiss JK et al. Increased risk of early measles in infants of human immunodeficiency virus type 1-seropositive mothers. Infect Dis 1992: 165:262-7.
[16]	Mayo-wilson E, Imdad A, herzer K, yakoob MY, Bhutta ZA. Vitamin A supplements for preventing mortality, illness, and blindness in children aged under 5: systematic review and meta-analysis. BMJ 2011; 343: d5094.
[17]	Fawzi WW, Chalmers TC, Herrera MG, Mosteller F. Vitamin A supplementation and child mortality. A meta-analysis. JAMA 1993; 269: 898-903.
[18]	Anonyme. La malnutrition protéino-énergétique sévère: traitement et conduit thérapeutique, Genève: Organisation mondiale de la santé: 1982.
[19]	G. Mortamet, J. Dina, F. Freymuth, B. Guillois, A. Vabret. Rougeole: que retenir de l’année 2011. Archives de pédiatrie 2012 ; 19 : 1269-1272.
[20]	F. Tall, B. Nacro, K. nagalo, P.S. Bonkoungou, Ha Traoré, He Traoré, A. roisin. Double épidémie de rougeole et de méningite à Bobo-Dioulasso (B.F.) au 1er semester 1996: données hospitalières pédiatriques. Méd. mal Infect. 1997; 27: 513-16.
[21]	Goodson JL, Masresha BG, Wannemuehler K, Uzicanin A, Cochi S. (2011). L'évolution de l'épidémiologie de la rougeole en Afrique. J Infect Dis. Juillet; 204 Suppl 1: S205-14. pmid: 21666163.
[22]	Zarocostas J. (2007). La mortalité par rougeole a diminué de 91% en Afrique entre 2000 et 2006. BMJ, 335 (7631), 1173. pmid: 18063626.
[23]	M. Caseris, C. Burdet, R. Lepeule, N. Houhou, P. Yeni, Y. Yazdanpanah, V. Joly. Actualité de la rougeole. La revue de médecine interne 2015 ; 36 : 339-345.